Cengage Learning

Encyclopedia of Pain, 1st Edition

  • Published By:
  • ISBN-10: 3540298053
  • ISBN-13: 9783540298052
  • Grade Level Range: College Freshman - College Senior
  • 2745 Pages | eBook
  • Original Copyright 2006 | Published/Released May 2007
  • This publication's content originally published in print form: 2006

    • Pricing for eBooks is based on your account type and population served. Accurate pricing will only display for registered users. Click here to register. Once registered, you will receive an email confirmation and can shop for titles with accurate pricing applied to your order. If you choose not to register, please call your sales representative at 1.800.877.4253 or email galeord@cengage.com.

  • Price:  Sign in for price

About

Overview

This is the most comprehensive overview available anywhere on the broad, multi-faceted and complex topic of pain and the rapidly evolving scientific and medical disciplines that seek to understand, assess and treat it. More than 3,000 entries provide clear, detailed and up-to-date coverage of the current state of research, and treatment of pain. Essays offer in-depth information on all aspects of nociception and pain, including substrates, causes, pathophysiology, symptoms and signs, diagnoses and treatment. 1,000 color figures enhance understanding. This three-volume reference is an invaluable tool for clinical scientists and practitioners, as well as students, teachers and interested laypersons.

Table of Contents

Front Cover.
Half Title Page.
Title Page.
Copyright Page.
Preface.
Editors-in-Chief.
Field Editors.
List of Contributors.
1: A Afferent Fibers (Neurons).
2: A Fibers (A-Fibers).
3: Abdominal Skin Reflex.
4: Abduction.
5: Aberrant Drug-Related Behaviors.
6: Ablation.
7: Abnormal Illness Affirming States.
8: Abnormal Illness Behavior.
9: Abnormal Temporal Summation.
10: Abnormal Ureteric Peristalsis in Stone Rats.
11: Abscess.
12: Absolute Detection Threshold.
13: Absorption.
14: Accelerometer.
15: Accommodation (of a Nerve Fiber).
16: Acculturation.
17: Accuracy and Reliability of Memory.
18: ACE-Inhibitors, Beta(β)-Blockers.
19: Acetylation.
20: Acetylcholine.
21: Acetylcholine Receptors.
22: Acidosis.
23: Acid-Sensing Ion Channels.
24: Acrylamide.
25: Action.
26: Action Potential.
27: Actiq.
28: Activa.
29: Activation Threshold.
30: Activation/Reassurance.
31: Active.
32: Active Inhibition.
33: Active Locus.
34: Active Myofascial Trigger Point.
35: Activities of Daily Living.
36: Activity.
37: Activity Limitations.
38: Activity Measurement.
39: Activity Mobilization.
40: Activity-Dependent Plasticity.
41: Acupuncture.
42: Acupuncture Efficacy.
43: Acupuncture Mechanisms.
44: Acupuncture-Like TENS.
45: Acute Pain in Children, Post-Operative.
46: Acute Pain.
47: Acute Pain in Children, Procedural.
48: Acute Pain Management in Infants.
49: Acute Pain Mechanisms.
50: Acute Pain Service.
51: Acute Pain Team.
52: Acute Pain, Subacute Pain and Chronic Pain.
53: Acute Phase Protein.
54: Acute Postoperative Pain Therapy.
55: Acute Stress Disorder.
56: Adaptation.
57: Adaptation Phase.
58: Adaptive Equipment.
59: Addiction.
60: Adduction.
61: Adenoassociated Virus Vectors.
62: Adenoma.
63: Adenomyosis.
64: Adenosine 5’ Triphosphate.
65: Adenoviral Vectors.
66: Adequate Stimulus.
67: Adherence.
68: Adhesion Molecules.
69: Adjunctive Drugs.
70: Adjusted Odds Ratio.
71: Adjustment Disorder.
72: Adjuvant.
73: Adjuvant Analgesic.
74: Adjuvant Analgesics in Management of Cancer-Rated Bone Pain.
75: Adjuvant Analgesics in Management of Cancer-Related Neuropathic Pain.
76: Adrenergic Agonist.
77: Adrenergic Antagonist.
78: Adrenoceptors.
79: Adverse Effects.
80: Adverse Neural Tension.
81: Adverse Selection.
82: Affective.
83: Affective Analgesia.
84: Affective Component (Aspekt, Dimension) of Pain.
85: Affective Responses.
86: Affective-Motivational.
87: Affective-Motivational Dimension of Pain.
88: Afferent Fiber/Afferent Neuron.
89: Afferent Projections.
90: Afferent Signal.
91: Afterdischarge(s).
92: Afterhyperpolarisation.
93: Age Regression.
94: Age-Related Pain Diagnoses.
95: Agonist.
96: Alcock’s Canal.
97: Alfentanil.
98: Algesic Agent / Algesic Chemical.
99: Algogen.
100: Algogenic Actions of Protons.
101: Algometer.
102: Alice-in-Wonderland Syndrome.
103: ALIF.
104: Alleles.
105: Allocortex.
106: Allodynia.
107: Allodynia (Clinical, Experimental).
108: Allodynia and Alloknesis.
109: Allodynia in Fibromyalgia.
110: Allodynia Test, Mechanical and Cold Allodynia.
111: Alloknesis.
112: Allostasis.
113: Alpha(α) 1-Adrenergic Receptor.
114: Alpha(α) 2-Adrenergic Agonist.
115: Alpha(α) 2-Adrenoceptor Agonists.
116: Alpha(α) 2-Adrenoceptors.
117: Alpha(α) 2-Adrenergic Agonists in Pain Treatment.
118: Alpha(α)-Adrenoceptors.
119: Alpha(α)-Delta(δ) Sleep.
120: Alpha(α)-D Galactose.
121: Alpha(α) EEG Wave Intrusion.
122: Alpha(α)-I-Acid Glycoprotein.
123: Alternative Medicine in Neuropathic Pain.
124: Alternative Rat Models of Ureteric Nociceptive Stimulation In Vivo.
125: Amelioration.
126: Amenorrhea.
127: American Society of Anesthesiologists’ Status Category.
128: Amide Anesthetic.
129: Aminobisphosphonate.
130: Amitriptyline.
131: AMPA Glutamate Receptor (AMPA Receptor).
132: Amphibian Peptides.
133: Amphipathic.
134: Amygdala.
135: Amygdala, Functional Imaging.
136: Amygdala, Pain Processing and Behavior in Animals.
137: Anaerobic Glycolysis.
138: Analgesia.
139: Analgesia During Labor and Delivery.
140: Analgesia for Labor and Delivery.
141: Analgesic Effect of Oxycodone.
142: Analgesic Gap.
143: Analgesic Guidelines for Infants and Children.
144: Analgesic Ladder.
145: Analgesic Treatment.
146: Analgesics.
147: Anaphylactic Reaction.
148: Anesthesia.
149: Anesthesia Dolorosa.
150: Anesthesia Dolorosa Model, Autotomy.
151: Anesthesiologist.
152: Anesthetic Blockade.
153: Aneurysm.
154: Anger and Pain.
155: Angina Pectoris.
156: Angina Pectoris, Neurophysiology and Psychophysics.
157: Angiogenesis.
158: Angiography.
159: Animal Models for Mononeuropathy.
160: Animal Models of Inflammatory Bowel Disease.
161: Animal Models and Experimental Tests to Study Nociception and Pain.
162: Ankylosing Spondylitis.
163: Ankylosis.
164: Annulus Fibrosus.
165: Anorexia.
166: Antecedents and Consequences of Behaviour.
167: Anterior Cingulate Cortex.
168: Anterior Primary Ramus.
169: Anterior Pulvinar Nucleus.
170: Anterograde Axonal Tracer (Anterograde Labeling).
171: Anterograde Transport.
172: Anterolateral Cordotomy.
173: Anticholinergics.
174: Anticipatory Anxiety.
175: Anticonvulsant (Agent).
176: Antidepressant Analgesics in Pain Management.
177: Antidepressant Drugs.
178: Antidepressants in Neuropathic Pain.
179: Antidromic Activation/Invasion.
180: Antidromic Microstimulation Mapping.
181: Antiepileptic Drugs (Agents).
182: Antihyperalgesic Effect.
183: Anti-Inflammatory Cytokines.
184: Antinociception.
185: Antinociceptive Effects of General Anesthetics.
186: Antinociceptive Models.
187: Antiphospholipid Syndrome.
188: Antisense Oligonucleotide.
189: Anxiety.
190: Anxiety Sensitivity.
191: Apamin.
192: Apoptosis.
Front Cover.
Half Title Page.
Title Page.
Copyright Page.
Preface.
Editors-in-Chief.
Field Editors.
List of Contributors.
1: A Afferent Fibers (Neurons).
2: A Fibers (A-Fibers).
3: Abdominal Skin Reflex.
4: Abduction.
5: Aberrant Drug-Related Behaviors.
6: Ablation.
7: Abnormal Illness Affirming States.
8: Abnormal Illness Behavior.
9: Abnormal Temporal Summation.
10: Abnormal Ureteric Peristalsis in Stone Rats.
11: Abscess.
12: Absolute Detection Threshold.
13: Absorption.
14: Accelerometer.
15: Accommodation (of a Nerve Fiber).
16: Acculturation.
17: Accuracy and Reliability of Memory.
18: ACE-Inhibitors, Beta(β)-Blockers.
19: Acetylation.
20: Acetylcholine.
21: Acetylcholine Receptors.
22: Acidosis.
23: Acid-Sensing Ion Channels.
24: Acrylamide.
25: Action.
26: Action Potential.
27: Actiq.
28: Activa.
29: Activation Threshold.
30: Activation/Reassurance.
31: Active.
32: Active Inhibition.
33: Active Locus.
34: Active Myofascial Trigger Point.
35: Activities of Daily Living.
36: Activity.
37: Activity Limitations.
38: Activity Measurement.
39: Activity Mobilization.
40: Activity-Dependent Plasticity.
41: Acupuncture.
42: Acupuncture Efficacy.
43: Acupuncture Mechanisms.
44: Acupuncture-Like TENS.
45: Acute Pain in Children, Post-Operative.
46: Acute Pain.
47: Acute Pain in Children, Procedural.
48: Acute Pain Management in Infants.
49: Acute Pain Mechanisms.
50: Acute Pain Service.
51: Acute Pain Team.
52: Acute Pain, Subacute Pain and Chronic Pain.
53: Acute Phase Protein.
54: Acute Postoperative Pain Therapy.
55: Acute Stress Disorder.
56: Adaptation.
57: Adaptation Phase.
58: Adaptive Equipment.
59: Addiction.
60: Adduction.
61: Adenoassociated Virus Vectors.
62: Adenoma.
63: Adenomyosis.
64: Adenosine 5’ Triphosphate.
65: Adenoviral Vectors.
66: Adequate Stimulus.
67: Adherence.
68: Adhesion Molecules.
69: Adjunctive Drugs.
70: Adjusted Odds Ratio.
71: Adjustment Disorder.
72: Adjuvant.
73: Adjuvant Analgesic.
74: Adjuvant Analgesics in Management of Cancer-Rated Bone Pain.
75: Adjuvant Analgesics in Management of Cancer-Related Neuropathic Pain.
76: Adrenergic Agonist.
77: Adrenergic Antagonist.
78: Adrenoceptors.
79: Adverse Effects.
80: Adverse Neural Tension.
81: Adverse Selection.
82: Affective.
83: Affective Analgesia.
84: Affective Component (Aspekt, Dimension) of Pain.
85: Affective Responses.
86: Affective-Motivational.
87: Affective-Motivational Dimension of Pain.
88: Afferent Fiber/Afferent Neuron.
89: Afferent Projections.
90: Afferent Signal.
91: Afterdischarge(s).
92: Afterhyperpolarisation.
93: Age Regression.
94: Age-Related Pain Diagnoses.
95: Agonist.
96: Alcock’s Canal.
97: Alfentanil.
98: Algesic Agent / Algesic Chemical.
99: Algogen.
100: Algogenic Actions of Protons.
101: Algometer.
102: Alice-in-Wonderland Syndrome.
103: ALIF.
104: Alleles.
105: Allocortex.
106: Allodynia.
107: Allodynia (Clinical, Experimental).
108: Allodynia and Alloknesis.
109: Allodynia in Fibromyalgia.
110: Allodynia Test, Mechanical and Cold Allodynia.
111: Alloknesis.
112: Allostasis.
113: Alpha(α) 1-Adrenergic Receptor.
114: Alpha(α) 2-Adrenergic Agonist.
115: Alpha(α) 2-Adrenoceptor Agonists.
116: Alpha(α) 2-Adrenoceptors.
117: Alpha(α) 2-Adrenergic Agonists in Pain Treatment.
118: Alpha(α)-Adrenoceptors.
119: Alpha(α)-Delta(δ) Sleep.
120: Alpha(α)-D Galactose.
121: Alpha(α) EEG Wave Intrusion.
122: Alpha(α)-I-Acid Glycoprotein.
123: Alternative Medicine in Neuropathic Pain.
124: Alternative Rat Models of Ureteric Nociceptive Stimulation In Vivo.
125: Amelioration.
126: Amenorrhea.
127: American Society of Anesthesiologists’ Status Category.
128: Amide Anesthetic.
129: Aminobisphosphonate.
130: Amitriptyline.
131: AMPA Glutamate Receptor (AMPA Receptor).
132: Amphibian Peptides.
133: Amphipathic.
134: Amygdala.
135: Amygdala, Functional Imaging.
136: Amygdala, Pain Processing and Behavior in Animals.
137: Anaerobic Glycolysis.
138: Analgesia.
139: Analgesia During Labor and Delivery.
140: Analgesia for Labor and Delivery.
141: Analgesic Effect of Oxycodone.
142: Analgesic Gap.
143: Analgesic Guidelines for Infants and Children.
144: Analgesic Ladder.
145: Analgesic Treatment.
146: Analgesics.
147: Anaphylactic Reaction.
148: Anesthesia.
149: Anesthesia Dolorosa.
150: Anesthesia Dolorosa Model, Autotomy.
151: Anesthesiologist.
152: Anesthetic Blockade.
153: Aneurysm.
154: Anger and Pain.
155: Angina Pectoris.
156: Angina Pectoris, Neurophysiology and Psychophysics.
157: Angiogenesis.
158: Angiography.
159: Animal Models for Mononeuropathy.
160: Animal Models of Inflammatory Bowel Disease.
161: Animal Models and Experimental Tests to Study Nociception and Pain.
162: Ankylosing Spondylitis.
163: Ankylosis.
164: Annulus Fibrosus.
165: Anorexia.
166: Antecedents and Consequences of Behaviour.
167: Anterior Cingulate Cortex.
168: Anterior Primary Ramus.
169: Anterior Pulvinar Nucleus.
170: Anterograde Axonal Tracer (Anterograde Labeling).
171: Anterograde Transport.
172: Anterolateral Cordotomy.
173: Anticholinergics.
174: Anticipatory Anxiety.
175: Anticonvulsant (Agent).
176: Antidepressant Analgesics in Pain Management.
177: Antidepressant Drugs.
178: Antidepressants in Neuropathic Pain.
179: Antidromic Activation/Invasion.
180: Antidromic Microstimulation Mapping.
181: Antiepileptic Drugs (Agents).
182: Antihyperalgesic Effect.
183: Anti-Inflammatory Cytokines.
184: Antinociception.
185: Antinociceptive Effects of General Anesthetics.
186: Antinociceptive Models.
187: Antiphospholipid Syndrome.
188: Antisense Oligonucleotide.
189: Anxiety.
190: Anxiety Sensitivity.
191: Apamin.
192: Apoptosis.